Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: Points of pathophysiological commonality with mood disorders?

Mood Disorders/Psychopharmacology Unit, University Health Network, University of Toronto, 399 Bathurst Street, Toronto, Ontario, Canada.
Advances in Therapy (Impact Factor: 2.44). 04/2010; 27(2):63-80. DOI: 10.1007/s12325-010-0011-z
Source: PubMed

ABSTRACT It is hypothesized that diabetes mellitus (DM) and mood disorders share points of pathophysiological commonality in the central nervous system.
A PubMed search of all English-language articles published between 1966 and March 2009 was performed with the following search terms: depression, mood disorders, hippocampus, amygdala, central nervous system, brain, neuroimaging, volumetric, morphometric, and neurocognitive deficits, cross-referenced with DM. Articles selected for review were based on adequacy of sample size, the use of standardized experimental procedures, validated assessment measures, and overall manuscript quality. The primary author was principally responsible for adjudicating the merit of articles that were included.
Volumetric studies indicate that individuals with Type 1/2 DM exhibit regional abnormalities in both cortical and subcortical (e.g., hippocampus, amygdala) brain structures. The pattern of neurocognitive deficits documented in individuals with Type 1 DM overlap with Type 2 populations, with suggestions of discrete abnormalities unique to each phenotype. The pattern of volumetric and neurocognitive deficits in diabetic populations are highly similar to that reported in populations of individuals with major depressive disorder.
The prevailing models of disease pathophysiology in DM and major depressive disorder are distinct. Notwithstanding, the common abnormalities observed in disparate effector systems (e.g., insulin resistance, immunoinflammatory activation) as well as brain volume and neurocognitive performance provide the nexus for hypothesizing that both conditions are subserved by overlapping pathophysiology. This conception provides a novel framework for disease modeling and treatment development in mood disorder.

Download full-text


Available from: Sidney H Kennedy, Jul 28, 2015
  • Source
    • "Our mediation findings extend prior findings linking peripheral physiological changes associated with the MetS and depressive symptomatology by identifying a potential mediating factor: reduced globus pallidus volume. As noted previously, this observation is consistent with prior findings and speculations that the MetS and depressive symptoms may share common pathophysiological features [22], including alterations in central neurotransmitter systems that covary with metabolic dysregulation [58] [59] and risk for depressive symptoms [81], as well as volume reductions in basal ganglia regions [74] [82]. Again, however, the causal directions of associations and temporal ordering of depressive symptoms, volumetric changes, and depressive symptoms need to be tested in future longitudinal research. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The metabolic syndrome (MetS) is a clustering of cardiovascular and cerebrovascular risk factors that are often comorbid with depressive symptoms. Individual components of the MetS also covary with the morphology of basal ganglia regions that are altered by depression. However, it remains unknown whether the covariation between the MetS and depressive symptomatology can be accounted for in part by morphological changes in the basal ganglia. Accordingly, we tested the hypothesis that increased depressive symptoms among individuals with the MetS might be statistically mediated by reduced grey matter volume in basal ganglia regions. The presence of the MetS was determined in 147 middle-aged adults using the criteria of the National Cholesterol Education Program, Adult Treatment Panel III. Basal ganglia volumes were determined on an a priori basis by automated segmentation of high-resolution magnetic resonance images. Depressive symptoms were assessed using the Patient Health Questionnaire. Even after controlling for demographic and other confounding factors, having the MetS and meeting more MetS criteria covaried with reduced globus pallidus volume. Meeting more MetS criteria and reduced pallidal volume were also related to depressive symptoms. Moreover, the MetS-depression association was statistically mediated by pallidal volume. In summary, reduced globus pallidus volume is a neural correlate of the MetS that may partly account for its association with depressive symptoms.
    Physiology & Behavior 10/2013; 123. DOI:10.1016/j.physbeh.2013.09.014 · 3.03 Impact Factor
  • Source
    • "A bi-directional relationship between obesity and cognitive function is suggested by studies reporting that individuals with impairment in executive function are more likely to become overweight or obese, perhaps related to disturbances in impulse control, self-monitoring, and goal-directed behaviour [24]. It is further hypothesized that cognitive abnormalities observed in overweight/obese individuals are the expression of abnormalities in brain structure and function [11] [16] [36]. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Persistent impairment in cognitive function has been described in euthymic individuals with bipolar disorder. Collective work indicates that obesity is associated with reduced cognitive function in otherwise healthy individuals. This sub-group post-hoc analysis preliminarily explores and examines the association between overweight/obesity and cognitive function in euthymic individuals with bipolar disorder. Euthymic adults with DSM-IV-TR-defined bipolar I or II disorder were enrolled. Subjects included in this post-hoc analysis (n=67) were divided into two groups (normal weight, body mass index [BMI] of 18.5-24.9 kg/m2; overweight/obese, BMI ≥ 25.0 kg/m2). Demographic and clinical information were obtained at screening. At baseline, study participants completed a comprehensive cognitive battery to assess premorbid IQ, verbal learning and memory, attention and psychomotor processing speed, executive function, general intellectual abilities, recollection and habit memory, as well as self-perceptions of cognitive failures. BMI was negatively correlated with attention and psychomotor processing speed as measured by the Digit Symbol Substitution Test (P<0.01). Overweight and obese bipolar individuals had a significantly lower score on the verbal fluency test when compared to normal weight subjects (P<0.05). For all other measures of cognitive function, non-significant trends suggesting a negative association with BMI were observed, with the exception of measures of executive function (i.e., trail making test B) and recollection memory (i.e., process-dissociation task). Notwithstanding the post-hoc methodology and relatively small sample size, the results of this study suggest a possible negative effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. Taken together, these data provide the impetus for more rigorous evaluation of the mediational role of overweight/obesity (and other medical co-morbidity) on cognitive function in psychiatric populations.
    European Psychiatry 05/2011; 27(3):223-8. DOI:10.1016/j.eurpsy.2011.02.004 · 3.21 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A new methyl-phenyl silsesquioxane SOG, GR 720, has been successfully used for a global, nonetchback intermetal planarization process. A double coat of GR 720 SOG is capable of filling submicron features with aspect ratios greater than 6, also producing global planarization without gaps, voids or cracks. The dielectric constant of GR 720 after a 400°C thermal cure was determined to be 2.9 at 1 MHz as measured by C-V techniques. TGA analysis demonstrates that the GR 720 SOG material is stable to 500°C. DSC analysis indicates that the solvents are removed at 130°C with no additional material evolution up to 500°C
    VLSI Multilevel Interconnection Conference, 1991, Proceedings., Eighth International IEEE; 07/1991
Show more